Update on feline upper respiratory diseases: Condition-specific recommendations

Compendium: Continuing Education For Veterinarians

Volumn 32, Issue 1, 2010, Pages

  Quimby, Jessica ^a   Lappin, Michael R ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); FELIDAE;

EID: 77957598011     PISSN: 19408307     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Helps CR, Lait P, Damhuis A, et al. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec 2005;156:669-773.
2. Di Martino B, Di Francesco CE, Meridiani I, Marsilio F. Etiological investigation of multiple respiratory infections in cats. New Microbiol 2007;30(4):455-461.
3. Gruffydd-Jones T, Addie D, Belák S, et al. Chlamydophila felis infection. ABCD guidelines on prevention and management. J Feline Med Surg 2009;11(7):605-609.
4. Egberink H, Addie D, Belák S, et al. Bordetella bronchiseptica infection in cats. ABCD guidelines on prevention and management. J Feline Med Surg 2009;11(7):610-614.
5. Pesavento PA, Bannasch MJ, Bachmann R, et al. Fatal Streptococcus canis infections in intensively housed shelter cats. Vet Pathol 2007;44:218-221.
6. Johnson LR, Foley JE, De Cock HE, et al. Assessment of infectious organisms associated with chronic rhinosinusitis in cats. JAVMA 2005;227:579-585.
7. Spindel ME, Veir JK, Radecki SV, Lappin MR. Evaluation of pradofloxacin for the treatment of feline rhinitis. J Feline Med Surg 2008;10:472-479.
8. Hartmann AD, Helps CR, Lappin MR, et al. Efficacy of pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or Mycoplasma infections. J Vet Intern Med 2008;22:44-52.
9. Schulz BS, Wolf G, Hartmann K. Bacteriological and antibiotic sensitivity results in 271 cats with respiratory infections. Vet Rec 2006;158:269-270.
10. Ruch-Gallie R, Veir JK, Spindel MM, Lappin MR. Efficacy of amoxicillin and azithromycin for the empirical treatment of cats with upper respiratory infections. J Feline Med Surg 2008;10:542-550.
11. Dossin O, Gruet P, Thomas E. Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections. J Small Anim Pract 1998;39:286-289.
12. Veir JK, Ruch-Gallie R, Spindel ME, Lappin MR. Prevalence of selected infectious organisms and comparison of two anatomic sampling sites in shelter cats with upper respiratory tract disease. J Feline Med Surg 2008;10(6):551-557.
13. Johnson LR, Kass PH. Effect of sample collection methodology on nasal culture results in cats. J Feline Med Surg 2009;11(8):645-649.
14. Welsh RD. Bordetella bronchiseptica infections in cats. JAAHA 1996;32:153-158.
15. Binns SH, Dawson S, Speakman AJ, et al. Prevalence and risk factors for feline Bordetella bronchiseptica infection. Vet Rec 1999;144:575-580.
16. Coutts AJ, Dawson S, Binns S, et al. Studies on natural transmission of Bordetella bronchiseptica in cats. Vet Microbiol 1996;48(1-2): 19-27.
17. Sykes JE, Studdert VP, Browning GF Comparison of the polymerase chain reaction and culture for the detection of feline Chlamydia psittaci in untreated and doxycyclinetreated experimentally infected cats. J Vet Intern Med 1999;13(3):146-152.
18. Di Francesco A, Donati M, Battelli G, et al. Seroepidemiological survey for Chlamydophila felis among household and feral cats in northern Italy. Vet Rec 2004;155(13):399-400.
19. Sparkes AH, Caney SMA, Sturgess CP, et al. The clinical efficacy of topical and systemic therapy for the treatment of feline ocular chlamydiosis. J Feline Med Surg 1999;1:31-35.
20. Gerhardt N, Schulz BS, Werckenthin C, et al. Pharmacokinetics of enrofloxacinand its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. Vet Rec 2006;159:591-594.
21. Sturgess CP, Gruffydd-Jones TJ, Harbour DA, Jones RL. Controlled study of the efficacy of clavulanic acid-potentiated amoxycillin in the treatment of Chlamydia psittaci in cats. Vet Rec 2001;149(3):73-76.
22. Beatty JA, Swift N, Foster DJ, Barrs VR. Suspected clindamycin-associated oesophageal injury in cats: 5 cases. J Feline Med Surg 2006;8:412-419.
23. German AJ, Cannon MJ, Dye C, et al. Oesophageal strictures in cats associated with doxycycline therapy. J Feline Med Surg 2005;7:33-41.
24. Melendez LD, Twedt DC, Wright M. Suspected doxycycline-induced esophagitis and esophageal stricture formation in three cats. Feline Pract 2000;28:10-12.
25. MacPhail CM, Bennett AD, Gibbons DS, Lappin MR. The esophageal transit time of tablets or capsules following administration with FlavorRx pill glide or pill delivery treats. J Vet Intern Med 2009;23:736.
26. Griffin B, Beard DM, Klopfenstein KA. Use of butter to facilitate the passage of tablets through the esophagus in cats. J Vet Intern Med 2003;17(3):445.
27. Westfall DS, Twedt DC, Steyn PF, et al. Evaluation of esophageal transit of tablets and capsules in 30 cats. J Vet Intern Med 2001;15:467-470.
28. Richards JR, Elston TH, Ford R, et al. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report. JAVMA 2006;229:1405-1441.
29. Dworkin MS, Sullivan PS, Buskin SE, et al. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1999;28:1095-1099.
30. Low HC, Powell CC, Veir JK, et al. Prevalence of feline herpesvirus 1, Chlamydophila felis, and Mycoplasma spp DNA in conjunctival cells collected from cats with and without conjunctivitis. Am J Vet Res 2007;68:643-648.
31. Moore GE, DeSantis-Kerr AC, Guptill LF, et al. Adverse events after vaccine administration in cats: 2, 560 cases (2002-2005). JAVMA 2007;231:94.
32. Sykes JE. Feline upper respiratory tract pathogens: Chlamydophila felis. Compend Contin Educ Pract Vet 2001;23:231-241.
33. Radford AD, Addie D, Belak S, et al. Feline calicivirus infection: ABCD guidelines on prevention and management. J Feline Med Surg 2009;11:556-564.
34. Turnquist SE, Ostlund E. Calicivirus outbreak with high mortality in a Missouri feline colony. J Vet Diag Invest 1997;9:195-198.
35. Pedersen NC, Elliott JB, Glasgow A, et al. An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus. Vet Microbiol 2000;73:281-300.
36. Hurley KF, Pesavento PA, Pedersen NC, et al. An outbreak of virulent systemic feline calicivirus disease. JAVMA 2004;224:241-249.
37. Schorr-Evans EM, Poland A, Johnson WE, Pedersen NC. An epizootic of highly virulent feline calicivirus disease in a hospital setting in New England. J Feline Med Surg 2003;5:217-226.
38. Coyne KP, Jones BR, Kipar A, et al. Lethal outbreak of disease associated with feline calicivirus infection in cats. Vet Rec 2006;158:544-550.
39. Kreutz LC, Johnson RP, Seal BS. Phenotypic and genotypic variation of feline calicivirus during persistent infection of cats. Vet Microbiol 1998;59:229-236.
40. Ossiboff RJ, Sheh A, Shotton H, et al. Feline caliciviruses (FCVs) isolated from cats with virulent systemic disease possess in vitro phenotypes distinct from those of other FCV isolates. J Gen Virol 2007;88:506-517.
41. Thiry E, Addie D, Belak S, et al. Feline herpesvirus infection: ABCD guidelines on prevention and management. J Feline Med Surg 2009;11:547-555.
42. Rampazzo A, Appino S, Pregel P, et al. Prevalence of Chlamydophila felis and feline herpesvirus 1 in cats with conjunctivitis in northern Italy. J Vet Intern Med 2003;17(6):799-807.
43. Maggs DJ, Clarke HE. Relative sensitivity of polymerase chain reaction assays used for detection of feline herpesvirus type 1 DNA in clinical samples and commercial vaccines. Am J Vet Res 2005;66(9):1550-1555.
44. Stiles J, McDermott M, Bigsby D, et al. Use of nested polymerase chain reaction to identify feline herpesvirus in ocular tissue from clinically normal cats and cats with corneal sequestra or conjunctivitis. Am J Vet Res 1997;58(4):338-342.
45. Maggs DJ, Lappin MR, Nasisse MP. Detection of feline herpesvirus-specific antibodies and DNA in the aqueous humor of cats with or without uveitis. Am J Vet Res 1999;60:932-936.
46. Thompkins WA. Immunomodulation and therapeutic effects of the oral use of interferon-α: mechanism of action. J Interferon Cytokine Res 1999;19:817-828.
47. De Mari K, Maynard L, Sanquer A., et al. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus infected and feline immunodeficiency virus coinfected symptomatic cats. J Vet Intern Med 2004;18:477-482.
48. Pedretti E, Passeri B, Amadori M, et al. Low-dose interferon-α treatment for feline immunodefciency virus infection. Vet Immunol Immunopathol 2006;109:245-254.
49. Maggs DJ, Clarke HE. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res 2004;65:399-403.
50. Nasisse MP, Dorman DC, Jamison KC, et al. Effects of valacyclovir in cats infected with feline herpesvirus 1. Am J Vet Res 1997;58(10):1141-1144.
51. Malik R, Lessels NS, Webb S, et al. Treatment of feline herpesvirus-1 associated disease in cats with famcyclovir and related drugs. J Feline Med Surg 2009;11:40-48.
52. Thomasy SM, Stanley SD, Lim CC, et al. Safety and efficacy of orally administered famciclovir in cats experimentally infected with feline herpesvirus 1. Am J Vet Res In review, 2009.
53. Fontenelle JP, Powell CC, Veir JK, et al. Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. Am J Vet Res 2008;69:289-293.
54. Maggs DJ, Collins BK, Thorne JG, Nasisse MP. Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1. Am J Vet Res 2000;61(12):1474-1478.
55. Maggs DJ, Nasisse MP, Kass PH. Efficacy of oral supplementation with L-lysine in cats latently infected with feline herpesvirus. Am J Vet Res 2003;64:37-42.
56. Lappin MR, Veir J, Sebring R, Radecki SV Feline lymphocyte blastogenesis in response to feline herpesvirus 1 antigens and concanavalin A after vaccination with five FVRCP vaccines [abstract]. J Vet Intern Med 2005;19:467.
57. Veir JK, Knorr R, Cavadini C, et al. Effect of oral supplementation with Enterococcus faecium SF68 on immune function in cats. Vet Ther 2007;8:229-238.
58. Lappin MR, Veir JK, Satyaraj E, Czarnecki-Maulden G. Pilot study to evaluate the effect of oral supplementation of Enterococcus faecium SF68 on cats with latent feline herpesvirus 1. J Feline Med Surg 2009;11:650-654.
59. Lappin MR, Sebring RW, Porter M, et al. Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1. J Feline Med Surg 2006;8:158-163.
60. Lappin MR, Veir J, Hawley JW. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative SPF cats after a single administration of 2 different modified live FVRCP vaccines. J Feline Med Surg 2009;11:159-162.
61. Porter CJ, Radford AD, Gaskell RM, et al. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates. J Feline Med Surg 2008;10(1):32-40.
62. Poulet H, Bruney S, Leroy V, Chappuis G. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges. Vet Microbiol 2005;106:17-31
63. Barrs VR, Beatty JA, Lingard AE, et al. Feline sino-orbital aspergillosis: an emerging clinical syndrome. Aust Vet J 2007;85: N23.
64. O'Brien CR, Krockenberger MB, Wigney DI, et al. Retrospective study of feline and canine cryptococcosis in Australia from 1981 to 2001:195 cases. Med Mycol 2004;42:449-460.
65. Malik R, Krockenberger M, O'Brien CR, et al. Cryptococcus. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 3rd ed. St. Louis: Elsevier; 2006:584-598.
66. O'Brien CR, Krockenberger MB, Martin P, et al. Long-term outcome of therapy for 59 cats and 11 dogs with cryptococcosis. Aust Vet J 2006;84(11):384-392.
67. Malik R, Wigney DI, Muir DB, et al. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fuconazole. J Med Vet Mycol 1992;30:133-144.
68. Greene CE, Hartmann K, Calpin J. Antimicrobial drug formulary. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 3rd ed. St. Louis: Elsevier; 2006:1200-1203.
69. Malik R, Craig AJ, Wigney DI, et al. Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. Aust Vet J 1996;73(4):124-128.
70. Flatland B, Greene RT, Lappin MR. Clinical and serologic evaluation of cats with cryptococcosis. JAVMA 1996;209:1110.
71. Tomsa K, Glaus TM, Zimmer C, Greene CE. Fungal rhinitis and sinusitis in three cats. JAVMA 2003;222:1380-1384.
72. Whitney BL, Broussard J, Stephanacci JD. Four cats with fungal rhinitis. J Feline Med Surg 2004;7:53-58.
73. Henderson SM, Bradley K, Day MJ, et al. Investigation of nasal disease in the cat-a retrospective study of 77 cases. J Feline Med Surg 2004;6:245-257.
74. Gaskell RM, Povey RC. Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec 1977;100:128-133.
75. Veir JK, Lappin MR, Dow SW. Evaluation of a novel immunotherapy for treatment of chronic rhinitis in cats. J Feline Med Surg 2006;8(6):400-411.
76. Kapatkin AS, Matthiesen DT, Noone KE, et al. Results of surgery and long-term follow-up in 31 cats with nasopharyngeal polyps. JAAHA 1990;26:387-392.
77. Holt DE. Nasopharyngeal polyps. In: King LG, ed. Textbook of Respiratory Disease in Dogs and Cats. Philadelphia: Saunders; 2004:328-332.
78. Baker GJ. Nasopharyngeal polyps in cats. Vet Rec 1982;111:43.
79. Veir JK, Lappin MR, Foley JE, Getzy DM. Feline inflammatory polyps: historical, clinical and PCR findings for feline calicivirus and feline herpesvirus 1 in 28 cases. J Feline Med Surg 2002;4:195-199.
80. Klose TC, Rosychuk RA, MacPhail CM, et al. Association between upper respiratory tract infections and infammatory aural and nasopharyngeal polyps in cats. J Vet Intern Med 2007;21:628.
81. Muilenberg RK, Fry TR. Feline nasopharyngeal polyps. Vet Clin North Am Small Anim Pract 2002;32(4):839-849.
82. Trevor PB, Martin RA. Tympanic bulla osteotomy for treatment of middle ear disease in cats: 19 cases (1984-1991). JAVMA 1993;202:123-128.
83. Demko JL, Cohn LA. Chronic nasal discharge in cats: 75 cases (1993-2004). JA VMA 2007;230:1032-1037.
84. Mukaratirwa S, van der Linde-Sipman JS, Gruys E. Feline nasal and paranasal sinus tumors: clinicopathological study, histomorphological description and diagnostic immunohistochemistry of 123 cases. J Feline Med Surg 2001;3:235-245.
85. Sfiligoi G, Theon AP, Kent MS. Response of nineteen cats with nasal lymphoma to radiation therapy and chemotherapy. Vet Radiol Ultrasound 2007;48:388-393.
86. Mellanby RJ, Herrtage ME, Dobson JM. Long-term outcome in eight cats with non-lymphoproliferative nasal tumours treated with megavoltage radiotherapy. J Feline Med Surg 2002;4:77-81.
87. DiBernardi L, Dore M, Davis JA, et al. Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment. Prostaglandins Leukot Essent Fatty Acids 2007;76(4):245-250.
88. Riley P. Nasopharyngeal grass foreign body in eight cats. JAVMA 1993;202:299-300.
89. Talavera Lopez J, Josefa Fernandez del Palacio M, Cano FG, Del Rio AB. Nasopharyngeal stenosis secondary to soft palate dysgenesis in a cat. Vet J 2008;181:200-204.
90. Berent AC, Weiss C, Todd K, et al. Use of a balloon-expandable metallic stent for treatment of nasopharyngeal stenosis in dogs and cats: six cases (2005-2007). JAVMA 2008;233:1432-1440.